In what it describes as a “customer-focused business structure,” CDMO Fujifilm Diosynth Biotechnologies has established separate small- and large-scale biomanufacturing units. The small-scale unit aims to support clients from preclinical all the way through the clinic until commercial production for biologics, cell and gene therapies, oncolytic viruses, and viral vaccines. The unit will leverage Fujifilm’s facilities in Teesside, UK, Triangle Park, North Carolina, College Station, Texas, Watertown, Massachusetts, and Thousand Oaks, California. The Large-Scale unit, meanwhile, will center on Fujifilm’s…

The Sacramento, California facility, key to Thermogenesis’ CDMO plan, will start welcoming customers by the end of the year. Thermogenesis, a medical device company specialised in base cell banking and cell therapy technology, is getting closer to becoming a full contract development and manufacturing organization (CDMO). “Our priority,” said Chris Xu, CEO, during a Q2 earnings conference call, “is to provide customers with solutions that optimize the supply chain, increasing manufacture, and manage overall risk.” The stepping stone to achieving…

AGC Biologics has added over 30,000 square feet of space to accommodate three cell therapy suites at its Longmont, Colorado site. The latest expansion sees contract development manufacturing organization (CDMO) AGC add two process suites and one flex suite at its Longmont plant, expanding the firm’s cell therapy capabilities. AGC said the additional capacity means the firm can offer its clients a full life cycle of cell therapy advancement and manufacturing services in one location. According to the company, the…